Dr. Thomas J. Reid, MD
Gynecologic Oncology (Gynecologic Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Wright State University Boonshoft School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 138
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Wright State University Boonshoft School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gynecologic Oncology Physician primary
OH license 35-073345 -
Obstetrics & Gynecology Physician
OH license 35073345
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Miami Valley Hospital Dayton, OH
- Kettering Health Dayton Dayton, OH
- Kettering Health Main Campus Kettering, OH
- Soin Medical Center Beaver Creek, OH
- Kettering Health Miamisburg Miamisburg, OH
Medical groups
- Kettering Independent Medical Group Inc (710 clinicians)
- Premier Health Specialists Inc (580 clinicians)
- Mercy Health Physicians Springfield Specialty Care LLC (135 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 138
- Services billed
- 454
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 216 | 54 |
| Established patient office or other outpatient visit, 30-39 minutes | 58 | 44 |
| New patient office or other outpatient visit, 60-74 minutes | 44 | 44 |
| Established patient office or other outpatient visit, 20-29 minutes | 27 | 25 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 21 | 18 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 18 | 11 |
| Imaging of lymph nodes during surgery | 16 | 16 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Hcl Other prescribers in Dayton, OH | 89 |
| Prochlorperazine Maleate Other prescribers in Dayton, OH | 65 |
| Magnesium Sulfate | 52 |
| Ondansetron Odt (ondansetron) Other prescribers in Dayton, OH | 49 |
| Olanzapine Other prescribers in Dayton, OH | 46 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Dayton, OH | 38 |
| Oxycodone Hcl Other prescribers in Dayton, OH | 37 |
| Neomycin Sulfate | 36 |
| Metronidazole Other prescribers in Dayton, OH | 35 |
| Tramadol Hcl Other prescribers in Dayton, OH | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $27,606 in research payments for these studies, mostly to the institutions running them.
- Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
AbbVie Inc. · Active, not recruiting · NCT05445778 - NIR-OGT-201
Springworks Therapeutics, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.